{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T17:37:04Z","timestamp":1789753024149,"version":"4.0.1"},"reference-count":55,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,26]],"date-time":"2025-11-26T00:00:00Z","timestamp":1764115200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,11,26]],"date-time":"2025-11-26T00:00:00Z","timestamp":1764115200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100018552","name":"Science and Technology Plan Project of Taizhou","doi-asserted-by":"publisher","award":["24ywb26"],"award-info":[{"award-number":["24ywb26"]}],"id":[{"id":"10.13039\/501100018552","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Transl Med"],"DOI":"10.1186\/s12967-025-07403-4","type":"journal-article","created":{"date-parts":[[2025,11,26]],"date-time":"2025-11-26T12:46:16Z","timestamp":1764161176000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["DCST1-AS1 promotes renal cell carcinoma progression via regulating the miR-582-5p\/HMGB2 axis"],"prefix":"10.1186","volume":"23","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0760-1418","authenticated-orcid":false,"given":"Chuanjing","family":"Dai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiannan","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiong","family":"Tian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanxi","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenyu","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shunqiao","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingmin","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,26]]},"reference":[{"key":"7403_CR1","doi-asserted-by":"publisher","first-page":"102558","DOI":"10.1016\/j.ctrv.2023.102558","volume":"116","author":"M Rizzo","year":"2023","unstructured":"Rizzo M, Cali\u00f2 A, Brunelli M, Pezzicoli G, Ganini C, Martignoni G, Camillo P. Clinico-pathological implications of the 2022 WHO renal cell carcinoma classification. Cancer Treat Rev. 2023;116:102558.","journal-title":"Cancer Treat Rev"},{"key":"7403_CR2","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.eururo.2018.08.036","volume":"75","author":"U Capitanio","year":"2019","unstructured":"Capitanio U, Bensalah K, Bex A, Boorjian SA, Bray F, Coleman J, Gore JL, Sun M, Wood C, Russo P. Epidemiology of renal cell carcinoma. Eur Urol. 2019;75:74\u201384.","journal-title":"Eur Urol"},{"key":"7403_CR3","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1038\/s41585-019-0211-5","volume":"16","author":"WM Linehan","year":"2019","unstructured":"Linehan WM, Ricketts CJ. The cancer genome atlas of renal cell carcinoma: findings and clinical implications. Nat Reviews Urol. 2019;16:539\u201352.","journal-title":"Nat Reviews Urol"},{"key":"7403_CR4","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1007\/s10142-022-00947-4","volume":"23","author":"T Loganathan","year":"2023","unstructured":"Loganathan T, Doss CGP. Non-coding RNAs in human health and disease: potential function as biomarkers and therapeutic targets. Funct Integr Genom. 2023;23:33.","journal-title":"Funct Integr Genom"},{"key":"7403_CR5","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1038\/nrg2521","volume":"10","author":"TR Mercer","year":"2009","unstructured":"Mercer TR, Dinger ME, Mattick JS. Long non-coding rnas: insights into functions. Nat Rev Genet. 2009;10:155\u20139.","journal-title":"Nat Rev Genet"},{"key":"7403_CR6","doi-asserted-by":"publisher","first-page":"2252","DOI":"10.1016\/j.molcel.2022.05.027","volume":"82","author":"AB Herman","year":"2022","unstructured":"Herman AB, Tsitsipatis D, Gorospe M. Integrated lncRNA function upon genomic and epigenomic regulation. Mol Cell. 2022;82:2252\u201366.","journal-title":"Mol Cell"},{"key":"7403_CR7","doi-asserted-by":"publisher","first-page":"e627","DOI":"10.1002\/iid3.627","volume":"10","author":"D Han","year":"2022","unstructured":"Han D, Ouyang G, Pan P, Yuan Y. Upregulated lncRNA-NEF predicts recurrence and poor treatment outcomes of ankylosing spondylitis. Immun Inflamm Dis. 2022;10:e627.","journal-title":"Immun Inflamm Dis"},{"key":"7403_CR8","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1038\/s41418-019-0363-0","volume":"27","author":"Q Zhang","year":"2020","unstructured":"Zhang Q, Li X, Cui K, Liu C, Wu M, Prochownik EV, Li Y. The MAP3K13-TRIM25-FBXW7\u03b1 axis affects c-Myc protein stability and tumor development. Cell Death Differ. 2020;27:420\u201333.","journal-title":"Cell Death Differ"},{"key":"7403_CR9","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1038\/s43018-021-00315-4","volume":"3","author":"A Xia","year":"2022","unstructured":"Xia A, Yuan W, Wang Q, Xu J, Gu Y, Zhang L, Chen C, Wang Z, Wu D, He Q, et al. The cancer-testis LncRNA lnc-CTHCC promotes hepatocellular carcinogenesis by binding HnRNP K and activating YAP1 transcription. Nat Cancer. 2022;3:203\u201318.","journal-title":"Nat Cancer"},{"key":"7403_CR10","doi-asserted-by":"publisher","first-page":"215798","DOI":"10.1016\/j.canlet.2022.215798","volume":"543","author":"J Yang","year":"2022","unstructured":"Yang J, Liu F, Wang Y, Qu L, Lin A. LncRNAs in tumor metabolic reprogramming and immune microenvironment remodeling. Cancer Lett. 2022;543:215798.","journal-title":"Cancer Lett"},{"key":"7403_CR11","doi-asserted-by":"crossref","unstructured":"Bridges MC, Daulagala AC, Kourtidis A. LNCcation: lncRNA localization and function. J Cell Biol. 2021:220.","DOI":"10.1083\/jcb.202009045"},{"key":"7403_CR12","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.semcdb.2021.05.029","volume":"124","author":"AA Farooqi","year":"2022","unstructured":"Farooqi AA, Attar R, Yulaevna IM, Berardi R. Interaction of long non-coding RNAs and circular RNAs with MicroRNAs for the regulation of immunological responses in human cancers. Semin Cell Dev Biol. 2022;124:63\u201371.","journal-title":"Semin Cell Dev Biol"},{"key":"7403_CR13","doi-asserted-by":"publisher","first-page":"216463","DOI":"10.1016\/j.canlet.2023.216463","volume":"578","author":"L Du","year":"2023","unstructured":"Du L, Wang B, Wu M, Chen W, Wang W, Diao W, Ding M, Chen W, Cao W, Guo H, Zhang G. LINC00926 promotes progression of renal cell carcinoma via regulating miR-30a-5p\/SOX4 axis and activating IFN\u03b3-JAK2-STAT1 pathway. Cancer Lett. 2023;578:216463.","journal-title":"Cancer Lett"},{"key":"7403_CR14","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1038\/s41419-021-03958-4","volume":"12","author":"J Wang","year":"2021","unstructured":"Wang J, Zou Y, Du B, Li W, Yu G, Li L, Zhou L, Gu X, Song S, Liu Y, et al. SNP-mediated lncRNA-ENTPD3-AS1 upregulation suppresses renal cell carcinoma via miR-155\/HIF-1\u03b1 signaling. Cell Death Dis. 2021;12:672.","journal-title":"Cell Death Dis"},{"key":"7403_CR15","first-page":"6827","volume":"25","author":"YZ Su","year":"2021","unstructured":"Su YZ, Cui MF, Du J, Song B. LncRNA DCST1-AS1 regulated cell proliferation, migration, invasion and apoptosis in gastric cancer by targeting miR-605-3p. Eur Rev Med Pharmacol Sci. 2021;25:6827.","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"7403_CR16","doi-asserted-by":"publisher","first-page":"819908","DOI":"10.3389\/fonc.2022.819908","volume":"12","author":"J Wang","year":"2022","unstructured":"Wang J, Shi P, Teng H, Lu L, Guo H, Wang X. Corrigendum: LncRNA DCST1-AS1 promotes endometrial cancer progression by modulating the MiR- 665\/HOXB5 and MiR-873-5p\/CADM1 pathways. Front Oncol. 2022;12:819908.","journal-title":"Front Oncol"},{"key":"7403_CR17","doi-asserted-by":"publisher","first-page":"1221","DOI":"10.2147\/CMAR.S234891","volume":"12","author":"J Ke","year":"2020","unstructured":"Ke J, Shen Z, Hu W, Li M, Shi Y, Xie Z, Wu D. LncRNA DCST1-AS1 was upregulated in endometrial carcinoma and May sponge miR-92a-3p to upregulate Notch1. Cancer Manage Res. 2020;12:1221\u20137.","journal-title":"Cancer Manage Res"},{"key":"7403_CR18","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1042\/CS20180814","volume":"133","author":"J Chen","year":"2019","unstructured":"Chen J, Wu D, Zhang Y, Yang Y, Duan Y, An Y. LncRNA DCST1-AS1 functions as a competing endogenous RNA to regulate FAIM2 expression by sponging miR-1254 in hepatocellular carcinoma. Clin Sci (London England: 1979). 2019;133:367\u201379.","journal-title":"Clin Sci (London England: 1979)"},{"key":"7403_CR19","doi-asserted-by":"crossref","unstructured":"Pokorn\u00e1 M, \u010cern\u00e1 M, Boussios S, Ovsepian SV, O\u2019Leary VB. LncRNA biomarkers of glioblastoma multiforme. Biomedicines. 2024:12.","DOI":"10.3390\/biomedicines12050932"},{"key":"7403_CR20","doi-asserted-by":"publisher","first-page":"e3308","DOI":"10.1002\/jgm.3308","volume":"24","author":"C Liang","year":"2022","unstructured":"Liang C, Wang J, Liu A, Wu Y. Tumor promoting long non-coding RNA CASC15 affects HMGB2 expression by sponging miR-582-5p in colorectal cancer. J Gene Med. 2022;24:e3308.","journal-title":"J Gene Med"},{"key":"7403_CR21","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1038\/s41417-021-00309-5","volume":"29","author":"F Wang","year":"2021","unstructured":"Wang F, Luo Y, Zhang L, Younis M, Yuan L. The LncRNA RP11-301G19.1\/miR-582-5p\/HMGB2 axis modulates the proliferation and apoptosis of multiple myeloma cancer cells via the PI3K\/AKT signalling pathway. Cancer Gene Ther. 2021;29:292\u2013303.","journal-title":"Cancer Gene Ther"},{"key":"7403_CR22","doi-asserted-by":"publisher","first-page":"383","DOI":"10.5114\/ceji.2024.145730","volume":"49","author":"Y Zhao","year":"2024","unstructured":"Zhao Y, Li Y, Su M, Cai X. Predictive value of miR-582-5p for onset of sepsis-induced acute kidney injury and its functional role during disease development. Central-European J Immunol. 2024;49:383\u201392.","journal-title":"Central-European J Immunol"},{"key":"7403_CR23","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1186\/s12943-025-02259-0","volume":"24","author":"X Du","year":"2025","unstructured":"Du X, Luo W, Li H, Gu Q, Huang P, Wang C, Li N, Liu F, Xia C. Hsa_circ_0125356 promotes gemcitabine resistance by modulating WNT canonical and non-canonical pathways via miR-582-5p\/FGF9 axis in non-small cell lung cancer. Mol Cancer. 2025;24:59.","journal-title":"Mol Cancer"},{"key":"7403_CR24","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.1016\/j.jgg.2021.07.017","volume":"48","author":"F Chen","year":"2021","unstructured":"Chen F, Guo L, Di J, Li M, Dong D, Pei D. Circular RNA ubiquitin-associated protein 2 enhances autophagy and promotes colorectal cancer progression and metastasis via miR-582-5p\/FOXO1 signaling. J Genet Genomics = Yi Chuan Xue Bao. 2021;48:1091\u2013103.","journal-title":"J Genet Genomics = Yi Chuan Xue Bao"},{"key":"7403_CR25","doi-asserted-by":"crossref","unstructured":"Huang S, Zou C, Tang Y, Wa Q, Peng X, Chen X, Yang C, Ren D, Huang Y, Liao Z et al. miR-582-3p and miR-582-5p suppress prostate cancer metastasis to bone by repressing TGF-\u03b2 signaling. Mol Therapy Nucleic Acids. 2019:16.","DOI":"10.1016\/j.omtn.2019.01.004"},{"key":"7403_CR26","doi-asserted-by":"crossref","unstructured":"Starkova T, Polyanichko A, Tomilin AN, Chikhirzhina E. Structure and functions of HMGB2 protein. Int J Mol Sci. 2023:24.","DOI":"10.3390\/ijms24098334"},{"key":"7403_CR27","first-page":"4729","volume":"24","author":"ZH He","year":"2020","unstructured":"He ZH, Guo F, Hu XX, Luo ZY, Yi JW. Knockdown of HMGB2 inhibits proliferation and invasion of renal tumor cells via the p-38MAPK pathway. Eur Rev Med Pharmacol Sci. 2020;24:4729\u201337.","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"7403_CR28","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1186\/s12885-024-12510-4","volume":"24","author":"J Hu","year":"2024","unstructured":"Hu J, Dai C, Ding Z, Pan Y, Lu L, Bao J, Zheng J. IKBIP promotes tumor development via the Akt signaling pathway in esophageal squamous cell carcinoma. BMC Cancer. 2024;24:759.","journal-title":"BMC Cancer"},{"key":"7403_CR29","doi-asserted-by":"publisher","first-page":"6451","DOI":"10.1016\/j.cell.2024.10.024","volume":"187","author":"L-L Chen","year":"2024","unstructured":"Chen L-L, Kim VN. Small and long non-coding rnas: Past, present, and future. Cell. 2024;187:6451\u201385.","journal-title":"Cell"},{"key":"7403_CR30","doi-asserted-by":"publisher","first-page":"5524231","DOI":"10.1155\/2021\/5524231","volume":"2021","author":"Y Ai","year":"2021","unstructured":"Ai Y, Liu S, Luo H, Wu S, Wei H, Tang Z, Li X, Zou C. LncRNA DCST1-AS1 facilitates oral squamous cell carcinoma by promoting M2 macrophage polarization through activating NF-\u03baB signaling. J Immunol Res. 2021;2021:5524231.","journal-title":"J Immunol Res"},{"key":"7403_CR31","doi-asserted-by":"publisher","first-page":"2230","DOI":"10.1007\/s12094-020-02363-1","volume":"22","author":"S Hu","year":"2020","unstructured":"Hu S, Yao Y, Hu X, Zhu Y. LncRNA DCST1-AS1 downregulates miR-29b through methylation in glioblastoma (GBM) to promote cancer cell proliferation. Clin Translational Oncology: Official Publication Federation Span Oncol Soc Natl Cancer Inst Mexico. 2020;22:2230\u20135.","journal-title":"Clin Translational Oncology: Official Publication Federation Span Oncol Soc Natl Cancer Inst Mexico"},{"key":"7403_CR32","doi-asserted-by":"publisher","first-page":"311","DOI":"10.7150\/jca.33982","volume":"11","author":"L Tang","year":"2020","unstructured":"Tang L, Chen Y, Tang X, Wei D, Xu X, Yan F. Long noncoding RNA DCST1-AS1 promotes cell proliferation and metastasis in Triple-negative breast cancer by forming a positive regulatory loop with miR-873-5p and MYC. J Cancer. 2020;11:311\u201323.","journal-title":"J Cancer"},{"key":"7403_CR33","doi-asserted-by":"publisher","first-page":"e3281","DOI":"10.1002\/jgm.3281","volume":"23","author":"J Liu","year":"2021","unstructured":"Liu J, Zhang J, Hu Y, Zou H, Zhang X, Hu X. Inhibition of LncRNA DCST1-AS1 suppresses proliferation, migration and invasion of cervical cancer cells by increasing miR-874-3p expression. J Gene Med. 2021;23:e3281.","journal-title":"J Gene Med"},{"key":"7403_CR34","doi-asserted-by":"publisher","first-page":"7921","DOI":"10.2147\/CMAR.S251582","volume":"12","author":"Z Zhou","year":"2020","unstructured":"Zhou Z, Xia N. LncRNA DCST1-AS1 sponges miR-107 to upregulate CDK6 in cervical squamous cell carcinoma. Cancer Manage Res. 2020;12:7921\u20138.","journal-title":"Cancer Manage Res"},{"key":"7403_CR35","first-page":"6091","volume":"23","author":"J Li","year":"2019","unstructured":"Li J, Zhai DS, Huang Q, Chen HL, Zhang Z, Tan QF. LncRNA DCST1-AS1 accelerates the proliferation, metastasis and autophagy of hepatocellular carcinoma cell by AKT\/mTOR signaling pathways. Eur Rev Med Pharmacol Sci. 2019;23:6091\u2013104.","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"7403_CR36","doi-asserted-by":"publisher","first-page":"639","DOI":"10.2217\/fon-2021-0923","volume":"18","author":"BC Cho","year":"2022","unstructured":"Cho BC, Felip E, Hayashi H, Thomas M, Lu S, Besse B, Sun T, Martinez M, Sethi SN, Shreeve SM, Spira AI. MARIPOSA: phase 3 study of first-line amivantamab\u2009+\u2009lazertinib versus osimertinib in EGFR-mutant non-small-cell lung cancer. Future Oncol (London England). 2022;18:639\u201347.","journal-title":"Future Oncol (London England)"},{"key":"7403_CR37","doi-asserted-by":"publisher","first-page":"280","DOI":"10.3389\/fonc.2020.00280","volume":"10","author":"L Tang","year":"2020","unstructured":"Tang L, Chen Y, Chen H, Jiang P, Yan L, Mo D, Tang X, Yan F. DCST1-AS1 promotes TGF-\u03b2-Induced Epithelial-Mesenchymal transition and enhances chemoresistance in Triple-Negative breast cancer cells via ANXA1. Front Oncol. 2020;10:280.","journal-title":"Front Oncol"},{"key":"7403_CR38","doi-asserted-by":"publisher","first-page":"1163","DOI":"10.1161\/CIRCRESAHA.119.314813","volume":"124","author":"J Bischoff","year":"2019","unstructured":"Bischoff J. Endothelial-to-Mesenchymal transition. Circul Res. 2019;124:1163\u20135.","journal-title":"Circul Res"},{"key":"7403_CR39","doi-asserted-by":"publisher","first-page":"554759","DOI":"10.3389\/fonc.2020.554759","volume":"10","author":"X Wu","year":"2020","unstructured":"Wu X, Sui Z, Zhang H, Wang Y, Yu Z. Integrated analysis of lncRNA-Mediated CeRNA network in lung adenocarcinoma. Front Oncol. 2020;10:554759.","journal-title":"Front Oncol"},{"key":"7403_CR40","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1186\/s12943-024-01944-w","volume":"23","author":"C Zhang","year":"2024","unstructured":"Zhang C, Yu Z, Yang S, Liu Y, Song J, Mao J, Li M, Zhao Y. ZNF460-mediated circRPPH1 promotes TNBC progression through ITGA5-induced FAK\/PI3K\/AKT activation in a CeRNA manner. Mol Cancer. 2024;23:33.","journal-title":"Mol Cancer"},{"key":"7403_CR41","doi-asserted-by":"crossref","unstructured":"Braga EA, Fridman MV, Moscovtsev AA, Filippova EA, Dmitriev AA, Kushlinskii NE. LncRNAs in ovarian cancer progression, metastasis, and main pathways: ceRNA and alternative mechanisms. Int J Mol Sci. 2020:21.","DOI":"10.3390\/ijms21228855"},{"key":"7403_CR42","doi-asserted-by":"publisher","first-page":"14981","DOI":"10.1038\/s41598-020-70913-2","volume":"10","author":"Y Hu","year":"2020","unstructured":"Hu Y, Su Y, Lei X, Zhao H, Wang L, Xu T, Guo J, Yang W, Zhang X. LINC00641\/miR-582-5p mediate oxaliplatin resistance by activating autophagy in gastric adenocarcinoma. Sci Rep. 2020;10:14981.","journal-title":"Sci Rep"},{"key":"7403_CR43","doi-asserted-by":"publisher","first-page":"11933","DOI":"10.2147\/CMAR.S274835","volume":"12","author":"Y Tian","year":"2020","unstructured":"Tian Y, Guan Y, Su Y, Luo W, Yang G, Zhang Y. MiR-582-5p inhibits bladder Cancer-Genesis by suppressing TTK expression. Cancer Manage Res. 2020;12:11933\u201344.","journal-title":"Cancer Manage Res"},{"key":"7403_CR44","doi-asserted-by":"publisher","first-page":"610992","DOI":"10.3389\/fonc.2021.610992","volume":"11","author":"J Xue","year":"2021","unstructured":"Xue J, Zhu S, Qi F, Zhu K, Cao P, Yang J, Wang Z. RUNX1\/miR-582-5p pathway regulates the tumor progression in clear cell renal cell carcinoma by targeting COL5A1. Front Oncol. 2021;11:610992.","journal-title":"Front Oncol"},{"key":"7403_CR45","doi-asserted-by":"publisher","first-page":"e172","DOI":"10.1161\/ATVBAHA.123.319916","volume":"44","author":"D Kong","year":"2024","unstructured":"Kong D, Liu J, Lu J, Zeng C, Chen H, Duan Z, Yu K, Zheng X, Zou P, Zhou L, et al. HMGB2 release promotes pulmonary hypertension and predicts severity and mortality of patients with pulmonary arterial hypertension. Arterioscler Thromb Vasc Biol. 2024;44:e172\u201395.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"7403_CR46","doi-asserted-by":"publisher","first-page":"eads8597","DOI":"10.1126\/sciadv.ads8597","volume":"11","author":"W-F Qu","year":"2025","unstructured":"Qu W-F, Zhu G-Q, Yang R, Chu T-H, Guan Z-Q, Huang R, Tian M-X, Jiang X-F, Tao C-Y, Fang Y, et al. Targeting HMGB2 acts as dual Immunomodulator by bolstering CD8\u2009+\u2009T cell function and inhibiting tumor growth in hepatocellular carcinoma. Sci Adv. 2025;11:eads8597.","journal-title":"Sci Adv"},{"key":"7403_CR47","doi-asserted-by":"crossref","unstructured":"Starkova TY, Polyanichko AM, Artamonova TO, Tsimokha AS, Tomilin AN, Chikhirzhina EV. Structural characteristics of high-mobility group proteins HMGB1 and HMGB2 and their interaction with DNA. Int J Mol Sci. 2023:24.","DOI":"10.3390\/ijms24043577"},{"key":"7403_CR48","doi-asserted-by":"publisher","first-page":"1415435","DOI":"10.3389\/fimmu.2024.1415435","volume":"15","author":"Y-Z Chen","year":"2024","unstructured":"Chen Y-Z, Meng Z-S, Xiang Z-L. HMGB2 drives tumor progression and shapes the immunosuppressive microenvironment in hepatocellular carcinoma: insights from multi-omics analysis. Front Immunol. 2024;15:1415435.","journal-title":"Front Immunol"},{"key":"7403_CR49","doi-asserted-by":"publisher","first-page":"868","DOI":"10.1038\/s41419-024-07248-7","volume":"15","author":"Z Guo","year":"2024","unstructured":"Guo Z, Li Z, Guo J, Gan L, Mo H, Zhang J, Fu Y, Wang Y, Jin M, Wu Y, et al. A N7-methylguanosine modified circular RNA, circIPP2A2, promotes malignant behaviors in hepatocellular carcinoma by serving as a scaffold in modulating the Hornerin\/PI3K\/AKT\/GSK3\u03b2 axis. Cell Death Dis. 2024;15:868.","journal-title":"Cell Death Dis"},{"key":"7403_CR50","doi-asserted-by":"publisher","first-page":"5889","DOI":"10.1158\/0008-5472.CAN-21-1538","volume":"81","author":"S Liang","year":"2021","unstructured":"Liang S, Guo H, Ma K, Li X, Wu D, Wang Y, Wang W, Zhang S, Cui Y, Liu Y, et al. A PLCB1-PI3K-AKT signaling axis activates EMT to promote cholangiocarcinoma progression. Cancer Res. 2021;81:5889\u2013903.","journal-title":"Cancer Res"},{"key":"7403_CR51","doi-asserted-by":"publisher","first-page":"17","DOI":"10.7150\/thno.36930","volume":"10","author":"S-J Zhao","year":"2020","unstructured":"Zhao S-J, Kong F-Q, Jie J, Li Q, Liu H, Xu A-D, Yang Y-Q, Jiang B, Wang D-D, Zhou Z-Q, et al. Macrophage MSR1 promotes BMSC osteogenic differentiation and M2-like polarization by activating PI3K\/AKT\/GSK3\u03b2\/\u03b2-catenin pathway. Theranostics. 2020;10:17\u201335.","journal-title":"Theranostics"},{"key":"7403_CR52","doi-asserted-by":"publisher","first-page":"8983","DOI":"10.1038\/sj.onc.1207115","volume":"22","author":"TF Franke","year":"2003","unstructured":"Franke TF, Hornik CP, Segev L, Shostak GA, Sugimoto C. PI3K\/Akt and apoptosis: size matters. Oncogene. 2003;22:8983\u201398.","journal-title":"Oncogene"},{"key":"7403_CR53","doi-asserted-by":"crossref","unstructured":"Li J, Xuan W, Yan R, Tropak MB, Jean-St-Michel E, Liang W, Gladstone R, Backx PH, Kharbanda RK, Redington AN. Remote preconditioning provides potent cardioprotection via PI3K\/Akt activation and is associated with nuclear accumulation of \u03b2-catenin. Clin Sci (London England: 1979). 2011;120:451\u201362.","DOI":"10.1042\/CS20100466"},{"key":"7403_CR54","doi-asserted-by":"publisher","first-page":"1414","DOI":"10.1111\/cas.13598","volume":"109","author":"H Jiang","year":"2018","unstructured":"Jiang H, Zhou Z, Jin S, Xu K, Zhang H, Xu J, Sun Q, Wang J, Xu J. PRMT9 promotes hepatocellular carcinoma invasion and metastasis via activating PI3K\/Akt\/GSK-3\u03b2\/Snail signaling. Cancer Sci. 2018;109:1414\u201327.","journal-title":"Cancer Sci"},{"key":"7403_CR55","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1038\/s41392-021-00762-6","volume":"7","author":"J Liu","year":"2022","unstructured":"Liu J, Xiao Q, Xiao J, Niu C, Li Y, Zhang X, Zhou Z, Shu G, Yin G. Wnt\/\u03b2-catenin signalling: function, biological mechanisms, and therapeutic opportunities. Signal Transduct Target Therapy. 2022;7:3.","journal-title":"Signal Transduct Target Therapy"}],"container-title":["Journal of Translational Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-025-07403-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12967-025-07403-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-025-07403-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,26]],"date-time":"2025-11-26T14:04:54Z","timestamp":1764165894000},"score":1,"resource":{"primary":{"URL":"https:\/\/translational-medicine.biomedcentral.com\/articles\/10.1186\/s12967-025-07403-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,26]]},"references-count":55,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["7403"],"URL":"https:\/\/doi.org\/10.1186\/s12967-025-07403-4","relation":{},"ISSN":["1479-5876"],"issn-type":[{"value":"1479-5876","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,26]]},"assertion":[{"value":"16 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Ethics Committee of Taizhou Hospital of Zhejiang Province (No. KL20241101) in accordance with the Declaration of Helsinki. Signed informed consent was provided by all participants. The animal experiment protocol was approved by the Animal Care Committee of Taizhou Hospital of Zhejiang Province (No. ty-20240701).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1352"}}